These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1755001)

  • 1. Human alpha- and zeta-thrombin inhibition by recombinant HV1 and HV2K47 hirudins.
    Witting JI; Brezniak DV; Hayes JR; Fenton JW
    Thromb Res; 1991 Aug; 63(4):473-9. PubMed ID: 1755001
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant hirudin: kinetic mechanism for the inhibition of human thrombin.
    Stone SR; Hofsteenge J
    Protein Eng; 1991 Feb; 4(3):295-300. PubMed ID: 1857714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin-specific inhibition by and slow cleavage of hirulog-1.
    Witting JI; Bourdon P; Brezniak DV; Maraganore JM; Fenton JW
    Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):737-43. PubMed ID: 1290488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hirulog-1 and -B2 thrombin specificity.
    Witting JI; Bourdon P; Maraganore JM; Fenton JW
    Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):663-4. PubMed ID: 1445227
    [No Abstract]   [Full Text] [Related]  

  • 5. CX-397, a novel recombinant hirudin analog having a hybrid sequence of hirudin variants-1 and -3.
    Komatsu Y; Misawa S; Sukesada A; Ohba Y; Hayashi H
    Biochem Biophys Res Commun; 1993 Oct; 196(2):773-9. PubMed ID: 8240353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the anticoagulant activities of thrombin inhibitors as assessed by thromboelastographic analysis.
    Callas D; Iqbal O; Fareed J
    Semin Thromb Hemost; 1995; 21 Suppl 4():76-9. PubMed ID: 8747693
    [No Abstract]   [Full Text] [Related]  

  • 7. Determination of the specific activity of recombinant hirudin.
    Eric D
    Thromb Res; 1990 Dec; 60(6):433-43. PubMed ID: 2082477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncompetitive inhibitor of thrombin.
    Koh CY; Kazimirova M; Nuttall PA; Kini RM
    Chembiochem; 2009 Sep; 10(13):2155-8. PubMed ID: 19644995
    [No Abstract]   [Full Text] [Related]  

  • 9. Hirudin and hirudin-based peptides.
    Stone SR; Maraganore JM
    Methods Enzymol; 1993; 223():312-36. PubMed ID: 8271960
    [No Abstract]   [Full Text] [Related]  

  • 10. Leech thrombin inhibitors.
    Salzet M
    Curr Pharm Des; 2002; 8(7):493-503. PubMed ID: 11945154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reevaluating the effects of tyrosine iodination of recombinant hirudin on its thrombin inhibition kinetics.
    Komatsu Y; Hayashi H
    Thromb Res; 1997 Aug; 87(4):343-52. PubMed ID: 9271811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin effects of native and recombinant hirudins.
    Markwardt F; Stürzebecher J; Glusa E
    Biomed Biochim Acta; 1990; 49(5):399-404. PubMed ID: 2271010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression, purification and characterization of multigram amounts of a recombinant hybrid HV1-HV2 hirudin variant expressed in Saccharomyces cerevisiae.
    Lehman ED; Joyce JG; Bailey FJ; Markus HZ; Schultz LD; Dunwiddie CT; Jacobson MA; Miller WJ
    Protein Expr Purif; 1993 Jun; 4(3):247-55. PubMed ID: 8518563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis for the inhibition of thrombin by hirudin.
    Stone SR; Betz A; Parry MA; Jackman MP; Hofsteenge J
    Adv Exp Med Biol; 1993; 340():35-49. PubMed ID: 8154342
    [No Abstract]   [Full Text] [Related]  

  • 15. Determination of specific activity of recombinant hirudin using a thrombin titration method.
    Iyer L; Fareed J
    Thromb Res; 1995 May; 78(3):259-63. PubMed ID: 7631307
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of hirudin as an antithrombotic agent.
    Markwardt F
    Semin Thromb Hemost; 1989 Jul; 15(3):269-82. PubMed ID: 2688099
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombin inhibition by synthetic hirudin peptides.
    Maraganore JM; Fenton JW
    Adv Exp Med Biol; 1990; 281():177-83. PubMed ID: 2102611
    [No Abstract]   [Full Text] [Related]  

  • 18. Interaction of hirudin with the dysthrombins Quick I and II.
    Stone SR; Schmitz T; Henriksen RA; Hofsteenge J; Dodt J
    Biochemistry; 1991 Jul; 30(26):6392-7. PubMed ID: 2054344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of recombinant hirudins.
    Stürzebecher J; Walsmann P
    Semin Thromb Hemost; 1991 Apr; 17(2):94-8. PubMed ID: 1771418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of in vitro clot growth by r-hirudin is more effective and longer sustained than by an analogous peptide.
    Römisch J; Stöhr HA; Stauss H; Koschinsky R; Stüber W; Pâques EP
    Thromb Haemost; 1994 Mar; 71(3):320-4. PubMed ID: 8029796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.